Wren Capital logo

Wren Capital

Europe, England, United Kingdom, London

Description

Wren Capital LLP is a nascent seed and early-stage investment fund based in London, United Kingdom, established in 2023. The firm positions itself as a crucial early backer for promising UK-based technology companies. With a strategic focus on the burgeoning deep tech, artificial intelligence (AI), and enterprise software sectors, Wren Capital aims to identify and nurture innovative startups poised for significant growth. Its recent inception underscores a commitment to contributing to the vibrant UK tech ecosystem, providing essential capital at the foundational stages of company development.

The fund's investment strategy is centered on providing initial capital to companies demonstrating strong potential within its core areas of interest. Wren Capital typically deploys first cheques ranging from £250,000 to £1,000,000. This investment size indicates their commitment to supporting companies through their critical early development phases, enabling them to achieve key milestones and attract subsequent funding rounds. The firm's hands-on approach likely involves more than just capital, offering strategic guidance and network access to its portfolio companies.

Wren Capital's geographic mandate is firmly rooted in the United Kingdom, specifically targeting companies within its borders. This localized focus allows the fund to develop deep expertise in the UK market dynamics and build strong relationships with founders and co-investors in the region. By concentrating on deep tech, AI, and enterprise software, Wren Capital aligns itself with some of the most transformative technological trends, seeking to back ventures that are developing proprietary, defensible technologies with significant market potential. The fund's relatively recent establishment in 2023 suggests a fresh perspective and agility in navigating the evolving landscape of early-stage venture capital.

Investor Profile

Wren Capital has backed more than 31 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Biopharma.
  • Typical check size: $317.5K – $1.3M.

Stage Focus

  • Seed (35%)
  • Series Unknown (26%)
  • Series A (26%)
  • Angel (6%)
  • Pre Seed (3%)
  • Equity Crowdfunding (3%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Genetics
  • Therapeutics
  • Hardware
  • Medical
  • Medical Device
  • Pharmaceutical
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wren Capital frequently co-invest with?

Martlet Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 4
UK Innovation & Science Seed Fund
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 6
ACF Investors
Europe, Sheffield, United Kingdom, Sheffield
Co-Investments: 9
Cambridge Angels group
Europe, England, United Kingdom, London
Co-Investments: 4
Midven
Europe, Birmingham, United Kingdom, Birmingham
Co-Investments: 3
Future Planet Capital
Europe, England, United Kingdom, London
Co-Investments: 6
O2h Ventures
Europe, Cambridgeshire, United Kingdom, Hauxton
Co-Investments: 5
University of Cambridge Enterprise
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 3
Parkwalk Advisors
Europe, England, United Kingdom, London
Co-Investments: 4
Newable Private Investing
Europe, England, United Kingdom, London
Co-Investments: 3

Which angels does Wren Capital often collaborate with?

JM
Europe, Isle of Man
Shared Deals: 1
David Evans
Oceania, New South Wales, Australia, Sydney
Shared Deals: 1
EP
Europe, England, United Kingdom
Shared Deals: 1
PC
Europe, England, United Kingdom, London
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 2

What are some of recent deals done by Wren Capital?

Monument Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Monument Therapeutics develops products to treat serious diseases of the central nervous system.

BiotechnologyHealth CarePharmaceutical
Series UnknownFeb 25, 2025
Amount Raised: $1,073,430
Spotta

Cambridge, Cambridgeshire, United Kingdom

Spotta is the creator of an ultra-low-power insect monitoring sensor meant to identify bed bug infestations.

HospitalityHousekeeping ServicePet
Series ADec 15, 2023
Amount Raised: $3,807,000
MitoRx Therapeutics

Harwell, Oxfordshire, United Kingdom

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.

BiotechnologyTherapeutics
SeedDec 13, 2023
Amount Raised: $5,048,523
Bastion Therapeutics

London, England, United Kingdom

Bastion Therapeutics is a preclinical stage biotechnology startup that uses proprietary platform technology to boost Them for immune system.

Biotechnology
Series UnknownSep 12, 2023
Amount Raised: $840,000
PharmEnable

Cambridge, Cambridgeshire, United Kingdom

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

BiotechnologyLife ScienceMedicalPharmaceutical
SeedMay 22, 2023
Amount Raised: $7,460,367
MitoRx Therapeutics

Harwell, Oxfordshire, United Kingdom

MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.

BiotechnologyTherapeutics
SeedApr 25, 2022
Adapttech

Birmingham, Birmingham, United Kingdom

Adapttech develops ingenious biomedical technologies to help people with physical limitations improve their quality of life

BiotechnologyMedical Device
Series AApr 6, 2022
Amount Raised: $2,940,569
Centauri Therapeutics

Sandwich, Kent, United Kingdom

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.

BiotechnologyGeneticsHealth CareMedicalTherapeutics
Series AFeb 16, 2022
Amount Raised: $32,596,295
Tay Therapeutics

Dundee, Dundee City, United Kingdom

Tay Therapeutics is a drug discovery company that develops the next generation of topical and oral therapies for inflammatory conditions.

BiopharmaBiotechnologyHealth CareHealth Diagnostics
SeedNov 2, 2021
Amount Raised: $2,178,783
Monument Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Monument Therapeutics develops products to treat serious diseases of the central nervous system.

BiotechnologyHealth CarePharmaceutical
SeedJul 1, 2021
Amount Raised: $3,611,747